PT-141 — Central Arousal Pathway
PT-141 (Bremelanotide) is a synthetic melanocortin-receptor agonist. Research investigates its effects on central-nervous-system mediated arousal pathways via melanocortin-4 receptor activation — a mechanism distinct from the vascular pathway of PDE5-inhibitor research.






